Hope

Mar 11, 20212 min read

Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial

Eli Lilly has rejoined the KRAS race months after toxicity forced it to dump its first candidate. The Big Pharma is set to enter phase 1...

Mar 6, 20217 min read

David Cox Forty years after the mutant genes that cause the deadliest cancers were discovered, drugs that target them could be approved...

Mar 1, 20213 min read

Like many other lung cancer patients, Terri Conneran’s road to diagnosis did not follow a direct route. For the entire summer leading up...

Feb 28, 20216 min read

Dusty Donaldson When Terri Conneran was first diagnosed with lung cancer, she focused on kicking cancer’s ass. That was before...

Feb 5, 20214 min read

Gina Kolata No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening. After 40 years of...

Jan 25, 20213 min read

IASLC Exciting New Research to be Presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer’s...

Jan 19, 202123 min read

KRAS is a frequent oncogenic driver in solid tumors, including non-small cell lung cancer (NSCLC). It was previously thought to be an...

Dec 4, 20203 min read

Korin Miller She hid her diagnosis from her kids on Christmas Day: ' I didn’t want to ruin their Christmas' Terri Conneran had been...

Feb 3, 20201 min read

KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten...

Upstage Lung Cancer heard the power of hope to kick cancer from Terri Conneran

Brief Summary “Up to 250 patients from anywhere in the United States can remotely consent and participate to have plasma drawn locally...

Rev Med reports out on the 46% of the pancreatic cancer patients who were enrolled in NCT05379985 (54% of patients are NSLC or other...